191 related articles for article (PubMed ID: 6605278)
1. Use of common antiplatelet drugs for vascular diseases.
Pagano T; Nair CK; Sketch MH
Geriatrics; 1983 Nov; 38(11):75-95. PubMed ID: 6605278
[No Abstract] [Full Text] [Related]
2. Platelet function inhibitors: their clinical use.
Fuster V; Didisheim P
Adv Intern Med; 1978; 23():251-64. PubMed ID: 343540
[No Abstract] [Full Text] [Related]
3. Antiplatelet agents: a review.
Gantmacher ML
J R Soc Med; 1979 Jul; 72(7):513-9. PubMed ID: 399644
[No Abstract] [Full Text] [Related]
4. Platelet suppressive therapy.
Turpie AG; Hirsh J
Br Med Bull; 1978 May; 34(2):183-90. PubMed ID: 350343
[No Abstract] [Full Text] [Related]
5. Management of thrombotic diseases.
Douglas AS
Semin Hematol; 1971 Apr; 8(2):95-139. PubMed ID: 4396057
[No Abstract] [Full Text] [Related]
6. Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
Harker LA; Hirsh J; Gent M; Genton E
Prog Hematol; 1975; 9():229-54. PubMed ID: 766074
[No Abstract] [Full Text] [Related]
7. [Treatment with antiplatelet drugs. Current status of knowledge].
Dettori AG; Pini M; Quintavalla R
Recenti Prog Med; 1979 Sep; 67(3):346-67. PubMed ID: 392656
[No Abstract] [Full Text] [Related]
8. Antiplatelet drugs in the management of patients with thrombotic disorders.
Harker LA
Semin Thromb Hemost; 1986 Apr; 12(2):134-55. PubMed ID: 3016905
[No Abstract] [Full Text] [Related]
9. A critical appraisal of the clinical efficiency of anti-platelet drugs.
Lecompte T; Samama M
Agents Actions Suppl; 1986; 20():203-14. PubMed ID: 3544741
[No Abstract] [Full Text] [Related]
10. Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).
Genton E; Gent M; Hirsh J; Harker LA
N Engl J Med; 1975 Dec; 293(23):1174-8. PubMed ID: 1102977
[No Abstract] [Full Text] [Related]
11. Actions and clinical status of platelet-suppressive agents.
Didisheim P; Fuster V
Semin Hematol; 1978 Jan; 15(1):55-72. PubMed ID: 341328
[No Abstract] [Full Text] [Related]
12. Treating thromboembolic disease.
Deykin D; Gurewich V; Harker L; Hirsch J
Geriatrics; 1977 Oct; 32(10):119-21, 125-8. PubMed ID: 302814
[No Abstract] [Full Text] [Related]
13. The current status of platelet suppressive drugs in the treatment of thrombosis.
Hirsh J; Gent M; Genton E
Thromb Diath Haemorrh; 1975 Jun; 33(3):406-16. PubMed ID: 1098213
[No Abstract] [Full Text] [Related]
14. Aspirin and other platelet-aggregation inhibiting drugs.
Gallus AS
Med J Aust; 1985 Jan; 142(1):41-7. PubMed ID: 3880861
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet drugs or dicoumarol: what is the most effective prophylaxis in occlusive arterial disease?
Poliwoda H; Avenarius HJ
Int Angiol; 1986; 5(3):169-80. PubMed ID: 2435823
[TBL] [Abstract][Full Text] [Related]
16. Platelet inhibitors in the treatment of thrombosis.
Hirsh J
Clin Invest Med; 1978; 1(3-4):191-206. PubMed ID: 391458
[No Abstract] [Full Text] [Related]
17. Platelet-inhibitor drugs' role in coronary artery disease.
Fuster V; Adams PC; Badimon JJ; Chesebro JH
Prog Cardiovasc Dis; 1987; 29(5):325-46. PubMed ID: 3547499
[No Abstract] [Full Text] [Related]
18. Using antithrombotic therapy in ischemic cerebrovascular disease.
Gotshall RA; Harker LA
Geriatrics; 1977 Nov; 32(11):101-4. PubMed ID: 924145
[No Abstract] [Full Text] [Related]
19. Antiplatelet agents in coronary disease: are they of prophylactic value?
Verstraete M
Drugs; 1978 Jun; 15(6):464-71. PubMed ID: 657992
[No Abstract] [Full Text] [Related]
20. Drug therapy: antiplatelet therapy (second of two parts).
Weiss HJ
N Engl J Med; 1978 Jun; 298(25):1403-6. PubMed ID: 349388
[No Abstract] [Full Text] [Related]
[Next] [New Search]
